Bin-Rong Yao

Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo

Ning Li, Wenyu Xin, Bin-Rong Yao et al. · European Journal of Medicinal Chemistry · 2018 · 61 citations

Medicinal Chemistry, Pharmaceutical Science, Medicine +10

N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines

Ning Li, Wenyu Xin, Bin-Rong Yao et al. · European Journal of Medicinal Chemistry · 2018 · 51 citations

Medicinal Chemistry, Activation Nf-κb Inhibitors, Medicine +10

Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation

Bin-Rong Yao, Yue Sun, Shuanglong Chen et al. · European Journal of Medicinal Chemistry · 2019 · 49 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9

Novel asymmetric 3,5-bis(arylidene)piperidin-4-one derivatives: synthesis, crystal structures and cytotoxicity

Bin-Rong Yao, Ning Li, Chunhua Wang et al. · Acta Crystallographica Section C Structural Chemistry · 2018 · 32 citations

Discovery of novel NF-кB inhibitor based on scaffold hopping: 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine

Yue Sun, Zhongfei Gao, Wei-Bin Yan et al. · European Journal of Medicinal Chemistry · 2020 · 23 citations

Molecular Pharmacology, Medicinal Chemistry, Scaffold Hopping +9